Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: A case-control study

Blood

Volumn 115, Issue 22, 2010, Pages 4344-4349

  Van Zaane, Bregje ^a,b   Squizzato, Alessandro ^b,c   Huijgen, Roeland ^b   Van Zanten, Anton P ^a   Fliers, Eric ^b   Cannegieter, Suzanne C ^d   Büller, Harry R ^b   Gerdes, Victor E A ^a,b   Brandjes, Dees P M ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; AUTOANTIBODY; AUTOANTIGEN; IODIDE PEROXIDASE; IRON BINDING PROTEIN; TPO PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FREE THYROXINE INDEX; HUMAN; LEG THROMBOSIS; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THYROID FUNCTION; THYROXINE BLOOD LEVEL; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CONFIDENCE INTERVAL; HYPERTHYROIDISM; IMMUNOLOGY; MIDDLE AGED; RISK; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; HYPERTHYROIDISM; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 77952725866     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-11-253724     Document Type: Article

References (36)

1. Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692-699. (Pubitemid 46563566)
2. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585-593.
3. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353(9159):1167-1173.
4. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 suppl 1):I4-I8.
5. Squizzato A, Romualdi E, Buller HR, Gerdes VE. Clinical review: thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab. 2007;92(7):2415-2420. (Pubitemid 47037335)
6. Dai A, Wasay M, Dubey N, Giglio P, Bakshi R. Superior sagittal sinus thrombosis secondary to hyperthyroidism. J Stroke Cerebrovasc Dis. 2000;9(2):89-90.
7. Lodha A, Haran M, Frankel R, Shani J. Thyrotoxicosis causing arterial and venous thrombosis. Am J Med Sci. 2009;338(5):428.
8. Siegert CE, Smelt AH, de Bruin TW. Superior sagittal sinus thrombosis and thyrotoxicosis. Possible association in two cases. Stroke. 1995;26(3):496-497.
9. Squizzato A, Vitale J, Gerdes VE, et al. Recurrent deep venous thrombosis during optimal anticoagulation and overt hyperthyroidism: a case report. Blood Coagul Fibrinolysis. 2007;18(8):801-803. (Pubitemid 350059340)
10. Verberne HJ, Fliers E, Prummel MF, et al. Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis. Thyroid. 2000;10(7):607-610. (Pubitemid 30670622)
11. Manfredi E, van Zaane B, Gerdes VE, Brandjes DP, Squizzato A. Hypothyroidism and acquired von Willebrand's syndrome: a systematic review. Haemophilia. 2008;14(3):423-433. (Pubitemid 351638727)
12. Kim BJ, Kim TY, Koh JM, et al. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol (Oxf). 2009;70(1):152-160.
13. Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148(11):832-845. (Pubitemid 351786932)
14. Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92(2):491-496. (Pubitemid 46255285)
15. Takamura N, Akilzhanova A, Hayashida N, et al. Thyroid function is associated with carotid intimamedia thickness in euthyroid subjects. Atherosclerosis. 2009;204(2):e77-e81.
16. Lensing AW, Prandoni P, Brandjes D, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med. 1989;320(6):342-345.
17. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349(13):1227- 1235.
18. Cooper DS. Hyperthyroidism. Lancet. 2003;362(9382):459-468.
19. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228-238.
20. Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004;363(9411):793-803.
21. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809-815. (Pubitemid 30165241)
22. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632-637.
23. Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematology Am Soc Hematol Educ Program. 2005;1-12.
24. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345(8943):152-155.
25. Canturk Z, Cetinarslan B, Tarkun I, et al. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid. 2003;13(10):971-977. (Pubitemid 37351881)
26. Chadarevian R, Bruckert E, Ankri A, et al. Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost. 1998;79(1):99-103. (Pubitemid 28037066)
27. Squizzato A, Romualdi E, Piantanida E, et al. Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study. Thromb Haemost. 2007;97(5):803-806. (Pubitemid 46779965)
28. Baumgartner-Parzer SM, Wagner L, Reining G, et al. Increase by tri-iodothyronine of endothelin- 1, fibronectin and von Willebrand factor in cultured endothelial cells. J Endocrinol. 1997;154(2):231-239. (Pubitemid 27330635)
29. Shih CH, Chen SL, Yen CC, et al. Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology. 2004;145(6):2804-2814.
30. Burggraaf J, Lalezari S, Emeis JJ, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid. 2001;11(2):153-160. (Pubitemid 32221038)
31. Liu L, Wang X, Lin Z, Wu H. Elevated plasma levels of VWF:Ag in hyperthyroidism are mediated through beta-adrenergic receptors. Endocr Res. 1993;19(2-3):123-133. (Pubitemid 23262251)
32. Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf). 1993;39(5):499-518.
33. Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab. 1997;82(12):4032-4036.
34. Begbie M, Notley C, Tinlin S, Sawyer L, Lillicrap D. The factor VIII acute phase response requires the participation of NFkappaB and C/EBP. Thromb Haemost. 2000;84(2):216-222.
35. Kraaijenhagen RA, Piovella F, Bernardi E, et al. Simplification of the diagnostic management of suspected deep vein thrombosis. Arch Intern Med. 2002;162(8):907-911.
36. Schutgens RE, Ackermark P, Haas FJ, et al. Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation. 2003;107(4):593-597.